People with NAFLD may have decreased expression of a liver enzyme needed for medication processing

People with non-alcoholic fatty liver disease (NAFLD) may process certain medications less effectively due to significantly decreased levels of an important enzyme, according to a new study from Indiana University School of Medicine. A team of researchers led by Nick Powell, PharmD, and Naga Chalasani, MD, published their findings in the article “Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease” in the journal Nature Communications in March.

Disruption from war in Ukraine pushes highly contagious infectious diseases to alarming levels

New research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15–18 April), reveals an extremely worrying picture of rising infectious diseases cases and falling levels of childhood vaccination and case detection in the eastern region of Ukraine in the city of Kharkiv and Kharkiv region, the scene of some of the most intense combat in 2022.